Clinical trial
Vascular Reactivity in Kidney Disease Patients
NCT00226902 · Melbourne Health, Other · Completed
Key facts
| NCT number | NCT00226902 |
|---|---|
| Title | Vascular Reactivity in Kidney Disease Patients |
| Official title | Integrated Studies in Vascular Reactivity and Anaemia Correction Therapy in Endstage Kidney Disease Patients |
| Lead sponsor | Melbourne Health, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic, Diabetes Mellitus, Type 1, Type 2 |
| Intervention type | Procedure |
| Interventions | Changing hemoglobin concentration |
| Enrollment | 15 |
| Start date | Sep 1, 2006 |
| Primary completion | Aug 1, 2013 |
| Completion | Sep 1, 2013 |
| First posted | Sep 27, 2005 |
| Last update posted | May 5, 2015 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: